AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Malaria vaccine based on parasite protein effective in animals.(Brief Article)

Vaccine Weekly

| March 13, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 MAR 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A vaccine based on a protein found on the surface of malaria-causing parasites protects animals from the disease, researchers in the United States and Japan report.

Hajime Hiseada and colleagues at the National Institutes of Health in Rockville, Maryland, and the University of Tokushima School of Medicine in Tokushima, Japan evaluated a "blood-stage vaccine based on Plasmodium falciparum merozoite surface protein 3 (MSP3)" in their study, published in the March 1, 2002 edition of the Journal of Infectious Diseases.

The vaccine studied was safe and effective in nonhuman primates, Hiseada and coworkers found.

They immunized seven Aotus nancymai monkeys with recombinant yeast expressing MSP3. Only one monkey required treatment for malaria after lethal Plasmodium falciparum challenge, compared with five of seven control animals, according to the report.

This MSP3 vaccine produced slightly better results than a vaccine based on merozoite surface protein (MSP) 1[subscript]42, study data showed. Two animals developed malaria after inoculation with an MSP1-based vaccine.

In addition, the ...

Related articles from newspapers, magazines, journals, and more
Aventis and U.S. NIH enter into pandemic influenza vaccine agreement.(Aventis...
Newspaper article from: BIOTECH Patent News May 1, 2004 700+ words
...agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes...NIH), to produce an investigational influenza vaccine based on a potential pandemic virus strain. Aventis...
Immunomedics Developing Vaccines for Cancer and Infectious Diseases.
Press release article from: PR Newswire February 2, 2000 700+ words
...for cancers and infectious diseases. "This patent...against cancers or infectious diseases. Fusion proteins...Company, covers a vaccine based upon the use of...therapy of cancer and infectious diseases. Other Vaccines...
CEL-SCI Receives Grant From the National Institute of Allergy And Infectious...
Press release article from: PR Newswire October 3, 2000 700+ words
...National Institute of Allergy and Infectious Diseases (NIAID) to further develop...of a herpes simplex virus vaccine based on CEL-SCI's patented...been identified, such as infectious diseases, cancer, autoimmune diseases...
Helicobacter pylori vaccine based on combined subproteome analysis.
Newspaper article from: Drug Week December 31, 2004 700+ words
...net) -- Scientists have developed a Helicobacter pylori vaccine based on combined subproteome analysis. According to a study...vaccines could provide long-term solutions to many important infectious diseases; however, vaccine development has been hampered by the...
Fighting Fire With Fire? Vaccine Based on Chimp Virus Shows Promise Against HIV.
News wire article from: Ascribe Higher Education News Service February 3, 2003 700+ words
...antibodies circulating in the blood able to impair any vaccine based on a common human adenovirus. But the new chimpanzee adenovirus...cancer, cardiovascular disease, autoimmune disorders, and infectious diseases. Founded in 1892 as the first institution of its kind...
Many adults blase about routine immunization.(Infectious Diseases)
Magazine article from: Family Practice News Splete, Heidi February 15, 2008 700+ words
...adults who were surveyed by the National Foundation for Infectious Diseases said they were unconcerned that either they or a family...would be "somewhat likely" or "very likely" to get a vaccine based on a doctor's recommendation. Although 49% of the respondents...
Many adults blase about receiving routine immunizations.(Infectious Diseases)
Magazine article from: Skin & Allergy News Splete, Heidi March 1, 2008 700+ words
...American adults surveyed by the National Foundation for Infectious Diseases said that they were unconcerned that either they or a family...either "somewhat likely" or "very likely" to get a vaccine based on a doctor's recommendation. Although 49% of the respondents...
Researchers at Japanese National Institute of Infectious Diseases Present New...
Press release article from: Business Wire October 23, 2006 700+ words
...Hideki Hasegawa, of Japan's National Institute of Infectious Diseases (JNIID), presented the results of his studies co-administering...accelerated track to commercialization for an influenza vaccine based solely on documented immunological improvements in humans...
Flu vaccine-naive children aged 5-8 years need two shots, study...
Magazine article from: Pediatric News Splete, Heidi November 1, 2006 700+ words
...a flu vaccine need two doses of trivalent inactivated influenza vaccine, based on antibody response data from 222 children in a prospective...a study of 222 children aged 5-8 years. Source: Journal of Infectious Diseases
An update on AIDS vaccine research. (U.S. National Institute of Allergy and...
Newspaper article from: AIDS Weekly January 6, 1992 700+ words
...primary goal of the U.S. National Institute of Allergy and Infectious Diseases (NIAID). NIAID's Research Strategy NIAID's AIDS...chimpanzee studies. Research findings also suggest that a vaccine based on one strain of SIV can protect monkeys against another...
For more facts and information, see all results

Source: HighBeam Research, Malaria vaccine based on parasite protein effective in animals.(Brief...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA